Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in increased expression of RARRES3 mRNA | increases expression | 17034753
|
C041819 |
4-oxoretinol |
4-oxoretinol results in increased expression of RARRES3 mRNA | increases expression | 17034753
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of RARRES3 protein | affects expression | 20106945
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of RARRES3 mRNA | increases expression | 17034753
|
C004984 |
apocarotenal |
apocarotenal results in decreased expression of RARRES3 mRNA | decreases expression | 17034753
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of RARRES3 mRNA | affects expression | 20382639
|
D019256 |
Cadmium Chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of RARRES3 mRNA | affects cotreatment|decreases expression | 12634122
|
C023600 |
chromium oxide |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of RARRES3 mRNA | affects cotreatment|decreases expression | 12634122
|
C017133 |
chromous chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of RARRES3 mRNA | affects cotreatment|decreases expression | 12634122
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of RARRES3 mRNA | increases expression | 20106945
|
D019833 |
Genistein |
Genistein results in increased expression of RARRES3 mRNA | increases expression | 15256057
|
C008261 |
lead acetate |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of RARRES3 mRNA | affects cotreatment|decreases expression | 12634122
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in decreased expression of RARRES3 mRNA | decreases expression | 12634122
|
C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of RARRES3 mRNA | decreases expression | 12727804
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of RARRES3 mRNA | affects cotreatment|decreases expression | 12634122
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of RARRES3 mRNA | decreases expression | 12727804 12634122
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of RARRES3 mRNA | increases expression | 16054129 17218384 17034753
|
D014801 |
Vitamin A |
Vitamin A results in increased expression of RARRES3 mRNA | increases expression | 17034753
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of RARRES3 mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000015 |
Abnormalities, Multiple |
|
Vitamin A |
4.82 | 10992263 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
2.47 | 11473722 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.67 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.87 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.58 | 15955085 |
MESH:D000740 |
Anemia |
|
Vitamin A |
4.48 | 16960172 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Vitamin A |
4.76 | 16960172 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.05 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.25 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
5.17 | 16456186 |
MESH:D001249 |
Asthma |
|
Vitamin A |
5.17 | 16732791 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.36 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.57 | 16197459 16206674 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.06 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.06 | 17200150 16873071 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.06 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
12.90 | 16813970 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Vitamin A |
12.90 | 17377406 17426644 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.89 | 16050911 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.13 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.55 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
6.55 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.55 | 15276417 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.55 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.65 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.65 | 16051514 16096774 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.27 | 16332659 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.07 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
15.82 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
15.82 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
15.82 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
15.82 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.55 | 16129372 |
MESH:D015362 |
Child Nutrition Disorders |
|
Vitamin A |
5.45 | 16153327 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.19 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Vitamin A |
8.19 | 16175620 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.13 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
6.28 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
Vitamin A |
6.28 | 16054864 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.66 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
4.12 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Vitamin A |
4.12 | 17219422 16267017 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
7.35 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
7.35 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
7.35 | 8800419 9211117 17551590 16925845 9125849 9224671 9142499 14991402 9664655 10589399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin A |
7.35 | 10992263 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
7.35 | 19769572 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Vitamin A |
3.49 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
2.48 | 16647724 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
2.99 | 18186108 |
MESH:D015352 |
Dry Eye Syndromes |
|
Vitamin A |
5.77 | 16146918 |
MESH:C538011 |
Eales disease |
|
Vitamin A |
13.03 | 9068938 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
13.03 | 9068938 |
MESH:D004480 |
Ectromelia |
|
Vitamin A |
5.79 | 16054864 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.44 | 18230668 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.55 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.46 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.46 | 16569247 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.06 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.54 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.82 | 19224547 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
5.34 | 19769572 |
MESH:D005327 |
Fetal Resorption |
|
Vitamin A |
5.34 | 16054864 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.56 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.56 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.64 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.18 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.11 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.11 | 17312396 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
5.04 | 19446573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.15 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.13 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.22 | 14991402 9664655 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin A |
11.22 | 16080930 10992263 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
11.22 | 16080930 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.39 | 15720958 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin A |
6.12 | 17436238 16292552 16490937 16877224 16863852 15707848 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
6.12 | 16490937 16863852 |
MESH:D015658 |
HIV Infections |
|
Vitamin A |
3.80 | 16960176 |
MESH:D006679 |
HIV Seropositivity |
|
Vitamin A |
5.56 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.11 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.94 | 14716179 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.18 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.53 | 16778211 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.08 | 10903974 |
MESH:D006986 |
Hypervitaminosis A |
|
Vitamin A |
6.14 | 16054864 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.96 | 12646999 15346721 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
4.19 | 16624496 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.73 | 17994277 |
MESH:D019586 |
Intracranial Hypertension |
|
Vitamin A |
5.79 | 15955940 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.86 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.41 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.60 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
14.28 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.28 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
14.28 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
14.28 | 12488133 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.70 | 12371664 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.34 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.34 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.66 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.07 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.12 | 19642359 19225113 16935935 9834237 17301526 17217047 17361223 17712046 17649720 17368321 17339181 16140955 16823087 16766008 17294898 15748426 19035177 16331271 19075265 19029980 17107899 12679006 16788101 17506722 16891316 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
8.40 | 9224671 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Vitamin A |
8.40 | 16054864 |
MESH:D008103 |
Liver Cirrhosis |
|
Vitamin A |
3.85 | 16256175 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
5.00 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
5.00 | 18397230 16248980 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin A |
5.00 | 16248980 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
5.00 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Vitamin A |
3.14 | 16175620 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Vitamin A |
5.12 | 16762690 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
4.63 | 15890375 18177683 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
4.63 | 15276417 16712894 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.29 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vitamin A |
6.29 | 17113696 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
12.29 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin A |
12.29 | 16863852 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
12.29 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.88 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
4.88 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.88 | 16712894 15276417 17077188 17306315 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
4.88 | 11062179 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
2.91 | 12929590 14578162 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.77 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.32 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.32 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.39 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.76 | 16801185 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.85 | 17671175 |
MESH:D009101 |
Multiple Myeloma |
|
Vitamin A |
4.02 | 16374440 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.81 | 18186108 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.05 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.84 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.63 | 17141266 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
8.29 | 16946489 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.29 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.29 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.63 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.41 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.24 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
9.68 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.68 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
17.19 | 10525206 18186108 19446573 11749123 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
17.19 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
17.19 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Vitamin A |
17.19 | 17400914 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.22 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.04 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
7.85 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.85 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.85 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.87 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.45 | 15976015 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.98 | 16144296 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.18 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.63 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.63 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.63 | 15084515 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.56 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.21 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.76 | 16723453 |
MESH:D012127 |
Respiratory Distress Syndrome, Newborn |
|
Vitamin A |
5.77 | 16877224 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.06 | 16116481 16283617 |
MESH:D012871 |
Skin Diseases |
|
Vitamin A |
5.23 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
5.23 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.73 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.73 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.76 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.48 | 16517955 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.99 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.75 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.20 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.49 | 16452187 11723127 16712894 17306315 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.28 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.28 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.58 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.96 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.39 | 17056641 |
MESH:D014802 |
Vitamin A Deficiency |
|
Vitamin A |
5.24 | 16175781 16146918 16960172 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.02 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.93 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.41 | 17120751 |